Advertisement

Angioimmunoblastic Lymphadenopathy

A Clinical View
  • David J. Stratus

Abstract

In the mid-1970s three groups of pathologists described a lymphomalike disorder associated with systemic symptoms and immunologic abnormalities. Frizzera18 et al. termed the disorder angioimmunoblastic lymphadenopathy (AILD), Lukes and Tindle33 immunoblastic lymphadenopathy and Radaszkiewicz and Lennert46 lymphogranulomatosis X.

Keywords

Mixed Lymphocyte Culture Cold Agglutinin Angioimmunoblastic Lymphadenopathy Mixed Lymphocyte Culture Reaction Bone Marrow Aspiration Smear 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andrieu JM, Youinou P, Herzog C: Levamisole and autoimmunity in angioimmunoblastic lymphadenopathy. Acta Haematol 62: 117–118, 1979PubMedCrossRefGoogle Scholar
  2. 2.
    Asher R, Burgher LW, Feagler JR: Immunoblastic lymphadenopathy presenting as pulmonary interstitial fibrosis. JAMA 237: 2411–2412, 1977PubMedCrossRefGoogle Scholar
  3. 3.
    Banik S, Ward RL, Hasleton PS: Immunoblastic lymphadenopathy; Evolution to immunoblastic sarcoma. J Clin Patho132:1101–1120, 1979Google Scholar
  4. 4.
    Bensa JC, Faure J, Martin H, Sotto JJ, Schaerer R: Levamisole in angioimmunoblastic lymphadenopathy (letter). Lancet 1: 1081, 1976PubMedCrossRefGoogle Scholar
  5. 5.
    Bessis M, Brecher G (eds): Hemopoietic Dysplasias (Preleukemic States). New York, Springer, 1977Google Scholar
  6. 6.
    Bluming AZ, Cohen HG, Saxon A: Angioimmunoblastic lymphadenopathy with dysproteinemia. A pathogenetic link between physiologic lymphoid proliferation and malignant lymphoma. Am J Med 67: 421–428, 1979PubMedCrossRefGoogle Scholar
  7. 7.
    Bradley SL, Dines DE, Banks PM, Hill RW: The lung in immunoblastic lymphadenopathy. Chest 80: 312–318, 1981PubMedCrossRefGoogle Scholar
  8. 8.
    Brincker H, Birkeland SA: The relationship between disease activity, treatment response, and immunologic reactivity in immunoblastic lymphadenopathy: A longitudinal study of treatment with levamisole and cytostatics. Cancer 47: 266–271, 1981PubMedCrossRefGoogle Scholar
  9. 9.
    Budman DR, Koziner B, Cunningham-Rundles C, Filippa D, Good RA: IgA deficiency associated with angioimmunoblastic lymphadenopathy. (Letter) N Engl J Med 298:1204, 1978PubMedGoogle Scholar
  10. 10.
    Case DC Jr, Clarkson BD, Lee BJ III:Improved survival in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63: 897–903, 1977PubMedCrossRefGoogle Scholar
  11. 11.
    Cibull ML, Seligson GR, Mouradian JA, Fialk MA, Pasmantier M: Immunoblastic lymphadenopathy and adenocarcinoma of the pancreas. A case report. Cancer 42: 1883–1885, 1978PubMedCrossRefGoogle Scholar
  12. 12.
    Cooperberg AA, de Champlain MB, Siminovitch J, Rosenberg A, Schwartz JP: Immunoblastic lymphadenopathy: Case report and literature review. Can Med Assoc J 117:53–57, 1977PubMedGoogle Scholar
  13. 13.
    Cullen MH, Stansfeld AG, Oliver RTD, Lister TA, Malpas JS: Angio-immunoblastic lymphadenopathy. Report of ten cases and review of the literature. Q J Med 48: 151–177, 1979PubMedGoogle Scholar
  14. 14.
    Deeg HJ, Singer JW, Huang TW: Angioimmunoblastic lymphadenopathy with retinitis and drug related exacerbations. A clinicopathological case study. Cancer 44: 1745–1750, 1979PubMedCrossRefGoogle Scholar
  15. 15.
    Ellegaard J, Boesen AM: Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol 17: 36–43, 1976PubMedCrossRefGoogle Scholar
  16. 16.
    Fisher RI, Jaffe ES, Brayland RC, Andersen JC, Tan HK: Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features. Am J Med 61: 553–559, 1976PubMedCrossRefGoogle Scholar
  17. 17.
    Fiorillo A, Pettinato G, Raia V, Mighorati R, Angrisani P, Buffolano W: Angioimmunoblastic lymphadenopathy with dysproteinemia: Report of the first case in childhood evolving toward spontaneous remission. Cancer 48: 1611–1614, 1981PubMedCrossRefGoogle Scholar
  18. 18.
    Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1: 1070–1073, 1974PubMedCrossRefGoogle Scholar
  19. 19.
    Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 59: 803–817, 1975PubMedCrossRefGoogle Scholar
  20. 20.
    Gan E, Van der Weyden MB: Hypercalcaemia and angioimmunoblastic lymphadenopathy. Br Med J 282: 437, 1981CrossRefGoogle Scholar
  21. 21.
    Garam T, Bak M, Bakacs T, Dobrentei E, Petranyi G: Angioimmunoblastic lymphadenopathy: A study of the function of lymphocyte populations. Cancer 47: 2850–2855, 1981PubMedCrossRefGoogle Scholar
  22. 22.
    Gleichmann E, Van Elven F, Gleichmann H: Immunoblastic lymphadenopathy, systemic lupus erythematosus and related disorders. Am J Clin Patho172:708–723, 1979Google Scholar
  23. 23.
    Gusterson BA, Fitzharris BM: Angioimmunoblastic lymphadenopathy with lupus erythematosus cells. Br,J Haematol 43: 149–150, 1979CrossRefGoogle Scholar
  24. 24.
    Hossfeld DK, Hoffken K, Schmidt CG, Diedrichs H: Chromosome abnormalities in angioimmunoblastic lymphadenopathy (letter). Lancet 1: 198, 1976PubMedCrossRefGoogle Scholar
  25. 25.
    Howarth CB, Bird CC: Immunoblastic sarcoma arising in a child with immunoblastic lymphadenopathy (letter). Lancet 2: 747–748, 1976PubMedCrossRefGoogle Scholar
  26. 26.
    Iseman MD, Schwartz MI, Stanford RE: Interstitial pneumonia in angioimmunoblastic lymphadenopathy with dysproteinemia. A case report with special histopathologic studies. Ann Intern Med 82: 75 2755, 1976Google Scholar
  27. 27.
    Kalus MJ: Immunoblastic lymphadenopathy. A report of two cases. Arch Pathol Lab Med 100:465–468, 1976PubMedGoogle Scholar
  28. 28.
    Klajman A, Yaretzky A, Schneider M, Holoshitz Y, Shnear A, Griffel B: Angioimmunoblastic lymphadenopathy with paraproteinemia: A T- and Bcell disorder. Cancer 48: 2433–2437, 1981PubMedCrossRefGoogle Scholar
  29. 29.
    Kosmidis PA, Axelrod AR, Palacas C, Stahl M: Angioimmunoblastic lymphadenopathy. A T-cell deficiency. Cancer 42: 447–452, 1978PubMedCrossRefGoogle Scholar
  30. 30.
    Kreisler JM, Moreno E, Moneo I Bootello A, Bouza E, Martinez de Letona J, Anaya A: Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunnl 27: 497–501, 1977Google Scholar
  31. 31.
    Krueger GRF, Bergholz M, Bartsch HH, Fischer R, Schauer A: Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL). J Cancer Res Clin Oncol 95: 8791, 1979CrossRefGoogle Scholar
  32. 32.
    Libshitz HI, Clouser M, Zornosa J, Osborne BM: Radiographic findings of immunoblastic lymphadenopathy and related immunoblastic proliferations. Am J Roentgenol 129: 875–878, 1975Google Scholar
  33. 33.
    Lukes RJ, Tindle BH: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8 1975PubMedCrossRefGoogle Scholar
  34. 34.
    Maguire FW, Mills RC, Parker FP: Immulloblastic lymphadenopathy and asbestosis. Cancer 47: 79 1797, 1981Google Scholar
  35. 35.
    Matz LR, Papadimitriou JM, Carroll JR, Barr AL, Dawkins RL, Jackson JM, Herrmann RP, Armstrong BK: Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer 40:2152–2160, 1977PubMedCrossRefGoogle Scholar
  36. 36.
    Mazur EM, Lovett DH, Enriquez RE, Berg WR, Papac RJ: Angioimmunoblastic lymphadenopathy. Evolution to a Burkitt-like lymphoma. Am J Med 67: 317–324, 1979PubMedCrossRefGoogle Scholar
  37. 37.
    Moore SB, Harrison EG, Weiland LH: Angioimmunoblastic lymphadenopathy. Mayo Clin Proc 51: 273–280, 1976Google Scholar
  38. 38.
    Naparstek Y, Ben-Chetrit E, Okon E, Estrov Z, Eliakim M: Angioimmunoblastic lymphadenopathy in a patient with allergy to insulin: A case report. Cancer 47: 545–547, 1981PubMedCrossRefGoogle Scholar
  39. 39.
    Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H: Maliganant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41: 578 - 606, 1978PubMedCrossRefGoogle Scholar
  40. 40.
    Neiman RS, Dervan P, Haudenschild C, Jaffe R: Angioimmunoblastic lymphadenopathy. An ultrastructural and immunologic study with review of the literature. Cancer 41: 507–518, 1978PubMedCrossRefGoogle Scholar
  41. 41.
    O–Donnell PP, Jiji R, Vigorito R, Price T: Angioimmunoblastic lymphadenopathy. Its association with meningeal involvement. Arch Neurol 37: 598 - 599, 1980PubMedCrossRefGoogle Scholar
  42. 42.
    Palutke M, Khilanani P, Weise R: Immunologic and electronmicroscopic characteristics of a case of immunoblastic lymphadenopathy. Am J Clin Pathol 65: 929–941, 1976Google Scholar
  43. 43.
    Pangalis GA, Moran EM, Rappaport H: Blood and bone marrow in angioimmunoblastic lymphadenopathy. Blood 51: 71–83, 1978PubMedGoogle Scholar
  44. 44.
    Pope RM, Cederbaum Al, Lewis W, Mannik M: Case report. Immunoblastic lymphadenopathy presenting as respiratory insufficiency. Am J Med Sci 274: 213–219, 1977PubMedCrossRefGoogle Scholar
  45. 45.
    Pruzanski W, Sutton DMC, Pantolony D: Angioimmunoblastic lymphadenopathy. An immunochemical study. Clin Immunol Immunopathol 6: 62–76, 1976PubMedCrossRefGoogle Scholar
  46. 46.
    Radaszkiewicz T, Lennert K: Lymphogranulomatosis X. Klinisches bild, therapie and prognose. Dtsch Med Wochenschr 100: 1157–1163, 1975PubMedCrossRefGoogle Scholar
  47. 47.
    Rudders RA, DeLellis R: Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol 68: 518 - 521, 1977PubMedGoogle Scholar
  48. 48.
    Salmon SE, Seligmann M: B-cell neoplasia in man. Lancet 2: 1230–1233, 1974PubMedCrossRefGoogle Scholar
  49. 49.
    Sampson D, Lui A: The effect of levamisole on cellmediated immunity and suppressor-cell function. Cancer Res 36: 952–955, 1976PubMedGoogle Scholar
  50. 50.
    Schauer, PK, Straus DJ, Bagley CM, Rudolf RH, McCracken JD, Huff J, Glucksberg H, Bauermeister DE, Clarkson BD: Angioimmunoblastic lymphadenopathy: Clinical spectrum of disease. Cancer 48: 2493–2498, 1981PubMedCrossRefGoogle Scholar
  51. 51.
    Schechter SL, Rosenblum D: Immunoblastic lymphadenopathy and hydroxychloroquine (letter). Arthritis Rheum 23: 256–257, 1980PubMedCrossRefGoogle Scholar
  52. 52.
    Schultz DR, Yunis AA: Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study. N Engl J Med 292: 8 - 12, 1975PubMedCrossRefGoogle Scholar
  53. 53.
    Seehafer JR, Goldberg NC, Dicken CH, Su WPD: Cutaneous manifestations of angioimmunoblastic lymphadenopathy. Arch Dermatol 116: 41–45, 1980PubMedCrossRefGoogle Scholar
  54. 54.
    Shamoto M, Suchi T: Intracytoplasmic type A virus-like particles in angioimmunoblastic lymphadenopathy. Cancer 44: 1641–1643, 1979PubMedCrossRefGoogle Scholar
  55. 55.
    Spector JI, Miller S: Immunoblastic lymphadenopathy. A report of two cases. JAMA 238: 1263–1265, 1977PubMedCrossRefGoogle Scholar
  56. 56.
    Symoens J, Rosenthal M: Levamisole in the modulation of the immune response: The current experimental and clinical state. J Reticuloendothel Soc 21: 175–221, 1977PubMedGoogle Scholar
  57. 57.
    Toth J, Garam T: Immunoblastic lymphadenopathy proceeding to sarcoma (letter). Lancet 1: 102, 1977PubMedCrossRefGoogle Scholar
  58. 58.
    Trenchard PM, Whittaker JA, Gough G, Parry H: Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy; possible contributions of immunoblastic leukemia, chemotherapy and multiple antibodies directed against mature cells. J Clin Pathol 34: 486–494, 1981PubMedCrossRefGoogle Scholar
  59. 59.
    Volk SLR, Monteleone PL, Knight WAK: Chromosomes in AILD (letter). N Engl J Med 292: 975, 1975PubMedGoogle Scholar
  60. 60.
    Wasser WG, Bockman RS, Alderete M, Alter AA: Immunoblastic lymphadenopathy with hypercalcemia. Mt Sinai J Med 47: 13–16, 1980PubMedGoogle Scholar
  61. 61.
    Watanabe M: Association of immunoblastic lymphadenopathy and Hashimoto’s thyroiditis. Ann Intern Med 87: 62–64, 1977PubMedGoogle Scholar
  62. 62.
    Wechsler HL, Stavrides A: Immunoblastic lymphadenopathy with purpura and cryoglobulinemia. Arch Dermatol 113: 636–641, 1977PubMedCrossRefGoogle Scholar
  63. 63.
    Weisenburger DD: Immunoblastic lymphadenopathy associated with methyldopa therapy. Cancer 42: 2322–2327, 1978PubMedCrossRefGoogle Scholar
  64. 64.
    Weisenburger D, Armitage J, Dick F: Immunoblastic lymphadenopathy with pulmonary infiltrates hypocomplementemia and vasculitis. Am J Med 63: 849–854, 1977PubMedCrossRefGoogle Scholar
  65. 65.
    Yataganas X, Papadimitriou C, Pangalis G, Loukopoulos D, Fessas P, Papacharalampous N: Angioimmunoblastic lymphadenopathy terminating as Hodgkin’s disease. Cancer 39: 2183–2189, 1977PubMedCrossRefGoogle Scholar
  66. 66.
    Zylak CJ, Banerjee R, Galbraith PA, McCarthy DS: Lung involvement in angioimmunoblastic lymphadenopathy (AIL). Radiology 121: 513–519, 1976PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1984

Authors and Affiliations

  • David J. Stratus

There are no affiliations available

Personalised recommendations